stockportfolio.pro
Stocks / BMY vs HCA
BMY vs HCA
Bristol-Myers Squibb Company and HCA Healthcare, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
BMY is the larger company ($112.9B vs $86.1B). On the fundamentals, HCA grows revenue faster (8.0% vs 2.5%); BMY earns a higher net margin (14.6% vs 9.0%); BMY has the stronger return on equity (38.2% vs -112.6%). Full numbers below — the stronger figure on each row is in green.
| Bristol-Myers Squibb Company (BMY) | HCA Healthcare, Inc. (HCA) | |
|---|---|---|
| Market cap | $112.9B | $86.1B |
| Revenue (latest FY) | $48.19B | $75.60B |
| Net income (latest FY) | $7.05B | $6.78B |
| Revenue growth (5y CAGR) | 2.5% | 8.0% |
| Net margin | 14.6% | 9.0% |
| Return on equity | 38.2% | -112.6% |
| P/E ratio | 15.5 | 13.4 |
| Dividend yield | 4.5% | — |
| Profitable years (of last 10) | 8 | 10 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full BMY vs HCA breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BMY's full financials → Open HCA's full financials →Frequently asked questions
Which is bigger, BMY or HCA?
Bristol-Myers Squibb Company is larger by market capitalization — $112.9B versus $86.1B.
Which grows faster, BMY or HCA?
Over the last five fiscal years, HCA Healthcare, Inc. grew revenue faster — 8.0%/yr versus 2.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.